Abstract
Malaria parasites that carry the DHFR-mutation I164L are not only highly resistant to sulfadoxine-pyrimethamine but also to the new antimalarial drug chlorproguanil-dapsone. The spread of this mutation in Africa would result in a public health disaster since there is a lack of effective alternatives that are both affordable and safe. Up to now, this mutation has only been described in Asian and Latin-American countries. The objective of this study was to assess the prevalence of this mutation in African isolates of Plasmodium falciparum that have been imported into Europe through travellers.
Cite
CITATION STYLE
Wichmann, O., Jelinek, T., Peyerl-Hoffmann, G., Mühlberger, N., Grobusch, M. P., … Gjørup, I. (2003). Molecular surveillance of the antifolate-resistant mutation I164L in imported african isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop. Malaria Journal, 2(1). https://doi.org/10.1186/1475-2875-2-17
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.